Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The Journal of Clinical Investigation
|
July 3, 2023
Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
Feyza Gul Ozbay Kurt, Samantha Lasser, Ihor Arkhypov, et al.
Cellular Immunology
|
December 9, 2020
IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy
Rebekka Weber, Christopher Groth, Samantha Lasser, et al.
Oncoimmunology
|
August 18, 2023
Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs
Alisa Lepper, Rebekka Bitsch, Feyza Gül Özbay Kurt, et al.
International Journal of Molecular Sciences
|
September 4, 2020
Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles
Ihor Arkhypov, Samantha Lasser, Vera Petrova, et al.
International Journal of Cancer
|
July 5, 2021
Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralization
Christopher Groth, Rebekka Weber, Samantha Lasser, et al.
International Journal of Molecular Sciences
|
June 27, 2024
Generation of Myeloid-Derived Suppressor Cells Mediated by MicroRNA-125a-5p in Melanoma
Samantha Lasser, Feyza Gul Ozbay Kurt, Lennart Fritz, et al.
Journal for Immunotherapy of Cancer
|
March 18, 2022
STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice
Rebekka Bitsch, Annina Kurzay, Feyza Özbay Kurt, et al.
Frontiers in Immunology
|
October 31, 2022
Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2
Feyza Gül Özbay Kurt, Alisa Lepper, Catharina Gerhards, et al.
Journal for Immunotherapy of Cancer
|
September 16, 2022
HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling
Ihor Arkhypov, Feyza Gül Özbay Kurt, Rebekka Bitsch, et al.
Cancers
|
February 13, 2021
Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression
Christopher Groth, Ludovica Arpinati, Merav E Shaul, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The Journal of Clinical Investigation
|
July 3, 2023
Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
Feyza Gul Ozbay Kurt, Samantha Lasser, Ihor Arkhypov, et al.
Cellular Immunology
|
December 9, 2020
IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy
Rebekka Weber, Christopher Groth, Samantha Lasser, et al.
Oncoimmunology
|
August 18, 2023
Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs
Alisa Lepper, Rebekka Bitsch, Feyza Gül Özbay Kurt, et al.
International Journal of Molecular Sciences
|
September 4, 2020
Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles
Ihor Arkhypov, Samantha Lasser, Vera Petrova, et al.
International Journal of Cancer
|
July 5, 2021
Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralization
Christopher Groth, Rebekka Weber, Samantha Lasser, et al.
International Journal of Molecular Sciences
|
June 27, 2024
Generation of Myeloid-Derived Suppressor Cells Mediated by MicroRNA-125a-5p in Melanoma
Samantha Lasser, Feyza Gul Ozbay Kurt, Lennart Fritz, et al.
Journal for Immunotherapy of Cancer
|
March 18, 2022
STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice
Rebekka Bitsch, Annina Kurzay, Feyza Özbay Kurt, et al.
Frontiers in Immunology
|
October 31, 2022
Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2
Feyza Gül Özbay Kurt, Alisa Lepper, Catharina Gerhards, et al.
Journal for Immunotherapy of Cancer
|
September 16, 2022
HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling
Ihor Arkhypov, Feyza Gül Özbay Kurt, Rebekka Bitsch, et al.
Cancers
|
February 13, 2021
Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression
Christopher Groth, Ludovica Arpinati, Merav E Shaul, et al.
Page
of 1